Authors:
LEGER G
GJEDDE A
KUWABARA H
GUTTMAN M
CUMMING P
Citation: G. Leger et al., EFFECT OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON BRAIN UPTAKE OF [F-18] FLUORODOPA - IMPLICATIONS FOR COMPARTMENTAL MODELING AND CLINICAL USEFULNESS, Synapse, 30(4), 1998, pp. 351-361
Citation: P. Croisille et al., COMPARISON OF DOBUTAMINE STRESS TAGGED MRI WITH F-18 FDG PET TO ASSESS MYOCARDIAL VIABILITY IN PATIENTS WITH CHRONIC ISCHEMIC-HEART-DISEASE, Journal of the American College of Cardiology, 31(2), 1998, pp. 384-384
Citation: D. Hussey et al., [C-11] RACLOPRIDE STRIATAL BINDING POTENTIAL AS A MEASURE OF HUNTINGTONS-DISEASE PROGRESSION - IMPLICATIONS FOR PROSPECTIVE NEUROPROTECTIVESTUDIES, The Journal of nuclear medicine, 39(5), 1998, pp. 932-932
Authors:
STEWART DJ
HUSSEY D
JONES C
HOULE S
THOMSON J
GUTTMAN M
Citation: Dj. Stewart et al., PET STUDIES IN PRESYMPTOMATIC AND SYMPTOMATIC HUNTINGTONS-DISEASE PATIENTS COMPARISON [F-18] FLUORODEOXYGLUCOSE, [C-11] RACLOPRIDE AND [C-11] SCH-23390, Neurology, 50(4), 1998, pp. 50003-50003
Authors:
FURUKAWA Y
LANG AE
TRUGMAN JM
BIRD TD
HUNTER A
SADEH M
TAGAWA T
STGEORGEHYSLOP PH
GUTTMAN M
MORRIS LW
HORNYKIEWICZ O
SHIMADZU M
KISH SJ
Citation: Y. Furukawa et al., GENDER-RELATED PENETRANCE AND DE-NOVO GTP-CYCLOHYDROLASE-I GENE-MUTATIONS IN DOPA-RESPONSIVE DYSTONIA, Neurology, 50(4), 1998, pp. 1015-1020
Authors:
KISH SJ
LOPESCENDES I
GUTTMAN M
FURUKAWA Y
PANDOLFO M
ROULEAU GA
ROSS BM
NANCE M
SCHUT L
ANG L
DISTEFANO L
Citation: Sj. Kish et al., BRAIN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-ACTIVITY IN HUMAN TRINUCLEOTIDE REPEAT DISORDERS, Archives of neurology, 55(10), 1998, pp. 1299-1304
Authors:
TAYLOR RP
FERGUSON PJ
MARTIN EN
COOKE J
GREENE KL
GRINSPUN K
GUTTMAN M
KUHN S
Citation: Rp. Taylor et al., IMMUNE-COMPLEXES BOUND TO THE PRIMATE ERYTHROCYTE COMPLEMENT RECEPTOR(CR-1) VIA ANTI-CR-1 MABS ARE CLEARED SIMULTANEOUSLY WITH LOSS OF CR-1 IN A CONCERTED REACTION IN A RHESUS-MONKEY MODEL, Clinical immunology and immunopathology, 82(1), 1997, pp. 49-59
Citation: P. Croisille et al., DOBUTAMINE STRESS TAGGED MRI TO ASSESS MYOCARDIAL VIABILITY IN PATIENTS WITH CHRONIC ISCHEMIC-HEART-DISEASE - COMPARISON WITH F-18 FDG PET, Radiology, 205, 1997, pp. 863-863
Authors:
GUTTMAN M
OTT E
TRAGNER H
BEDARD PJ
POURCHER E
CURRAN T
GOODRIDGE A
GUTTMAN M
HOBSON D
KING D
MARTIN WRW
MENDIS T
RAJPUT A
RIVEST J
STOESSL J
SUCHOWERSKY O
MORAN J
MURPHY R
WALSH B
ONEILL DO
KLEMPERER B
MARTIN M
OEHLWEIN C
POLZER U
REICHMANN H
SCHIMEK J
SCHLENKER M
SCHWARTZ A
MEIER D
TRAUBNER P
BENETIN J
BOMHOF MAM
HOVESTADT A
VREELING FW
WOLTERS ECMJ
BRODDIE HG
CLARKE C
CLOUGH CJ
LOIZOU L
NEWMAN PK
PYE IF
Citation: M. Guttman et al., DOUBLE-BLIND COMPARISON OF PRAMIPEXOLE AND BROMOCRIPTINE TREATMENT WITH PLACEBO IN ADVANCED PARKINSONS-DISEASE, Neurology, 49(4), 1997, pp. 1060-1065
Authors:
GUTTMAN M
BURKHOLDER J
KISH SJ
HUSSEY D
WILSON A
DASILVA J
HOULE S
Citation: M. Guttman et al., [C-11] RTI-32 PET STUDIES OF THE DOPAMINE TRANSPORTER IN EARLY DOPA-NAIVE PARKINSONS-DISEASE - IMPLICATIONS FOR THE SYMPTOMATIC THRESHOLD, Neurology, 48(6), 1997, pp. 1578-1583
Authors:
KISH SJ
GUTTMAN M
ROBITAILLE Y
ELAWAR M
CHANG LJ
LEVEY AI
Citation: Sj. Kish et al., STRIATAL DOPAMINE NERVE-TERMINAL MARKERS BUT NOT NIGRAL CELLULARITY ARE REDUCED IN SPINOCEREBELLAR ATAXIA TYPE-1, Neurology, 48(4), 1997, pp. 1109-1111
Citation: M. Guttman, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO COMPARE THE SAFETY, TOLERANCE AND EFFICACY OF PRAMIPEXOLE AND BROMOCRIPTINE IN ADVANCED PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 32003-32003
Authors:
KIEBURTZ K
PENNEY JB
COMO P
RANEN N
SHOULSON I
FEIGIN A
ABWENDER D
GREENAMYRE JT
HIGGINS D
MARSHALL FJ
GOLDSTEIN J
STEINBERG K
SHIH C
RICHARD I
HICKEY C
ZIMMERMAN C
ORME C
CLAUDE K
OAKES D
SAX DS
KIM A
HERSCH S
JONES R
AUCHUS A
OLSEN D
BISSEYBLACK C
RUBIN A
SCHWARTZ R
DUBINSKY R
MALLONEE W
GRAY C
GODFREY N
SUTER G
SHANNON KM
STEBBINS GT
JAGLIN JA
MARDER K
TAYLOR S
LOUIS E
MOSKOWITZ C
THORNE D
ZUBIN N
WEXLER N
SWENSON MR
PAULSEN J
SWERDLOW N
ALBIN R
WERNETTE C
WALKER F
HUNT V
ROOS RAC
YOUNG AB
KOROSHETZ W
BIRD E
MEYERS R
CUDKOWICZ M
GUTTMAN M
STCYR J
BURKHOLDER J
LUNDIN A
ASHIZAWA T
JANKOVIC J
SIEMERS E
QUAID K
MARTIN W
SANCHEZRAMOS J
FACCA A
REY G
SUCHOWERSKY O
ROHS G
KLINEK ML
ROSS C
BYLSMA FW
SHERR M
HAYDEN M
RAYMOND L
CLARK C
KREMER B
Citation: K. Kieburtz et al., UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY, Movement disorders, 11(2), 1996, pp. 136-142
Authors:
PRZEDBORSKI S
DONALDSON D
JAKOWEC M
KISH SJ
GUTTMAN M
ROSOKLIJA G
HAYS AP
Citation: S. Przedborski et al., BRAIN SUPEROXIDE-DISMUTASE, CATALASE, AND GLUTATHIONE-PEROXIDASE ACTIVITIES IN AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 39(2), 1996, pp. 158-165
Authors:
WILSON JM
LEVEY AI
RAJPUT A
ANG L
GUTTMAN M
SHANNAK K
NIZNIK HB
HORNYKIEWICZ O
PIFL C
KISH SJ
Citation: Jm. Wilson et al., DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE, Neurology, 47(3), 1996, pp. 718-726
Authors:
GUTTMAN M
BURKHOLDER J
KISH S
WILSON A
HOULE S
Citation: M. Guttman et al., [C-11] RTI-32 PET STUDIES OF THE DOPAMINE TRANSPORTER IN EARLY DOPA-NAIVE PARKINSONS-DISEASE, Neurology, 46(2), 1996, pp. 6089-6089
Authors:
KUWABARA H
CUMMING P
YASUHARA Y
LEGER GC
GUTTMAN M
DIKSIC M
EVANS AC
GJEDDE A
Citation: H. Kuwabara et al., REGIONAL STRIATAL DOPA TRANSPORT AND DECARBOXYLASE ACTIVITY IN PARKINSONS-DISEASE, The Journal of nuclear medicine, 36(7), 1995, pp. 1226-1231
Authors:
GUTTMAN M
LEGER G
RECHES A
EVANS A
KUWABARA H
CEDARBAUM JM
GJEDDE A
Citation: M. Guttman et al., ADMINISTRATION OF THE NEW COMT INHIBITOR OR-611 INCREASES STRIATAL UPTAKE OF FLUORODOPA, Movement disorders, 8(3), 1993, pp. 298-304
Authors:
GJEDDE A
LEGER GC
CUMMING P
YASUHARA Y
EVANS AC
GUTTMAN M
KUWABARA H
Citation: A. Gjedde et al., STRIATAL L-DOPA DECARBOXYLASE ACTIVITY IN PARKINSONS-DISEASE IN-VIVO - IMPLICATIONS FOR THE REGULATION OF DOPAMINE SYNTHESIS, Journal of neurochemistry, 61(4), 1993, pp. 1538-1541